ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,950Medicare Part D Prescriptions Filled, Including Refills

Rank: 136 out of 783

$658K Total Retail Price of All Prescriptions

Rank: 160 out of 783

419 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Indiana
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 419 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

20% of this provider’s 419 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

5% of this provider’s 10,704 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Indiana
OMEPRAZOLE 554 444 1 6
LISINOPRIL 496 473 2 4
FUROSEMIDE 443 397 3 7
LEVOTHYROXINE SODIUM 440 359 4 1
HYDROCODONE-ACETAMINOPHEN 354 294 S3 5 2
AMLODIPINE BESYLATE 344 330 6 5
POTASSIUM CHLORIDE 324 290 7 16
SIMVASTATIN 320 287 8 3
ATENOLOL 301 280 9 17
METFORMIN HCL 206 180 10 8
CITALOPRAM HBR 198 173 11 19
GUANFACINE HCL 180 180 R 12 312
GABAPENTIN 146 135 13 15
TAMSULOSIN HCL 133 113 14 26
HYDROCHLOROTHIAZIDE 126 124 15 12
METOPROLOL SUCCINATE 120 120 16 13
ALLOPURINOL 120 114 16 31
FENTANYL 120 106 S2 16 65
NABUMETONE 118 96 19 178
POLYETHYLENE GLYCOL 3350 117 107 20 43
KLOR-CON 10 115 108 21 102
ALENDRONATE SODIUM 113 113 22 25
ISOSORBIDE MONONITRATE ER 110 103 23 40
LOSARTAN POTASSIUM 106 101 24 18
ATORVASTATIN CALCIUM 103 91 25 11
CARVEDILOL 101 95 26 21
TRIAMTERENE-HCTZ 97 97 27 42
ZETIA 96 86 28 80
NEXIUM 95 94 29 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 92 87 30 33
PANTOPRAZOLE SODIUM 91 81 31 30
LOSARTAN-HYDROCHLOROTHIAZIDE 91 85 31 53
CLONIDINE HCL 89 89 33 60
FAMOTIDINE 87 85 34 55
TRAMADOL HCL 84 65 35 20
GLYBURIDE 83 76 R 36 111
NAMENDA 83 83 36 32
PREDNISONE 82 74 38 36
FLUTICASONE PROPIONATE 81 80 39 46
METOPROLOL TARTRATE 74 65 40 9
MELOXICAM 73 64 41 37
AMITRIPTYLINE HCL 69 60 R 42 77
SULFAMETHOXAZOLE-TRIMETHOPRIM 68 63 43 95
CIPROFLOXACIN HCL 65 60 44 62
WARFARIN SODIUM 64 55 45 10
PREMARIN 63 63 R 46 176
DILTIAZEM 24HR CD 63 63 46 118
CELEBREX 63 63 46 93
SERTRALINE HCL 57 57 49 22
CYMBALTA 57 47 49 35
FINASTERIDE 57 54 49 127
DIGOXIN 54 54 52 61
CLOPIDOGREL 53 47 53 29
MECLIZINE HCL 53 41 53 146
ATENOLOL-CHLORTHALIDONE 52 51 55 213
GEMFIBROZIL 51 48 56 105
VENLAFAXINE HCL ER 50 42 57 100
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.